A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)

BACKGROUND: COVID-19 has quickly become a global pandemic with a substantial number of deaths and is a considerable burden for healthcare systems worldwide. Although most cases are paucisymptomatic and limited to the viral infection-related symptoms, some patients evolve to a second phase, with an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Malchair, Pierre, Otero, Aurema, Giol, Jordi, Solanich, Xavier, Carnaval, Thiago, Fernández-Nistal, Alonso, Sánchez-Gabriel, Ana, Montoto, Carmen, Lleonart, Ramon, Videla, Sebastián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003174/
https://www.ncbi.nlm.nih.gov/pubmed/35413921
http://dx.doi.org/10.1186/s13063-022-06219-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003174/
https://www.ncbi.nlm.nih.gov/pubmed/35413921
http://dx.doi.org/10.1186/s13063-022-06219-7

Ejemplares similares